Patrick Wilson and Vera Farmiga as Ed and Lorraine Warren fight the forces of evil in 'The Conjuring' Image via Warner Bros. Horror movies deal with themes of cults, demons, the paranormal, black ...

From Resident Evil to Werwulf, here are all the new horror movies coming our way in 2026 and 2027 ...

The filmmaker has some tantalizing answers to questions audiences are left with at the end of her installment.

From genre-defining hits ('Sinners') and surprise breakouts ('Weapons') to hidden gems ('Dead Mail') and auteur-driven awards contenders ('Frankenstein'), these were the best scares studios and ...

One scene from the continuation of “28 Years Later” has Fiennes’s character performing to the song “The Number of the Beast.” A look at how the filmmakers pulled it off.

Zack Snyder continues to share photos from his time in the DCEU to his new Instagram page, and his latest post features a never-before-seen black-and-white shot of Michael Shannon as General Zod.

Sure, that’s an understatement. But nothing underscores just how different a company Nvidia is today than the fact that it didn’t announce a single new consumer GPU this year at CES. Instead, Huang ...

There’s a theory about store-bought bone broth that has been making the rounds on social media, and our expert backs it up. “In the greater scheme of things, a lot of the bone broth that is being sold ...

Nia DaCosta, spoke about the ending of 28 Years Later: The Bone Temple in an interview with THR. She gave insights into Murphy's role and is excited as how the story is now moving forward.

So, I was one of the many who lit up at the news that she would be directing 28 Years Later: The Bone Temple, part two in a trilogy developed by 28 Days Later creators Danny Boyle and Alex Garland.

Taking the stage at a packed Fontainebleau Las Vegas venue, Huang said the computing industry is undergoing a once-in-a-decade transition — and this time, two shifts are happening simultaneously.

Ultragenyx Pharmaceutical has reported the failure of a pair of late-phase brittle bone disease trials, prompting the biotech to prepare to significantly reduce its spending. The studies tested the ...